Table 1 Characteristics of patients following myocardial infarction, Tayside

	Prehospital		In-hospital				Post-hospital
	Dead		Dead		Alive		Dead		Alive
	No	%	No	%	No	%	No	%	No	%
Distance (miles)†
<3	1287	31.7	407	41.6	1753	33.0**	678	36.5	1075	31.1**
3–9	1346	33.2	304	31.0	1801	33.9	607	32.7	1194	34.6
>8	1423	35.1	268	27.4	1756	33.1	572	30.8	1184	34.3
Sex
Male	2029	49.1	443	43.9	3270	60.6**	1017	53.3	2253	64.5**
Female	2104	50.9	567	56.1	2128	39.4	890	46.7	1238	35.6
Age (mean, SD)	77.2	10.9	78.5	9.6	67.5	12.6**	74.6	10.2	63.7	12.1**
Deprivation category†
1, least deprived	175	4.4	47	4.8	313	5.9	100	5.4	213	6.1
2	833	20.9	172	17.4	980	18.4	325	17.6	655	18.8
3	1187	29.8	312	31.6	1508	28.3	502	27.3	1006	28.8
4	424	10.7	122	12.3	561	10.5	216	11.7	345	9.9
5	487	12.2	111	11.2	648	12.2	221	12.0	427	12.2
6+, most deprived	876	23.0	225	22.8	1320	24.8	478	26.0	742	24.1
Travel time (mean, SD)	–	–	17.3	15.3	19.3	14.9**	20.4	15.7	18.7	15.4**
Urban-rural code‡
1	1603	40.5	385	38.6	2356	44.0**	813	43.5	1543	44.2
2	1003	25.4	289	29.0	1410	26.3	527	28.2	883	25.3
3, 6	1181	29.9	280	18.0	1431	26.7	467	25.0	964	27.6
7, 8	167	4.2	44	4.4	163	3.0	62	3.3	101	2.9
Previous hospitalisation
Angina	445	10.8	121	12.0	691	12.8	295	15.5	396	11.3**
Heart failure	845	20.5	277	27.4	1402	26.0**	821	43.1	581	16.6**
Stroke	433	10.5	111	11.0	271	5.0**	173	9.1	98	2.8**
Hypertension	432	10.5	131	13.0	645	12.0*	233	12.2	412	11.8**
PVD	462	11.2	128	12.7	423	7.8**	232	12.2	191	5.5**
Diabetes	567	13.7	146	14.5	715	13.2	327	17.2	388	11.1**
Cardiovascular drug use in the previous year‡
Lipid-lowering drug	325	7.9	97	9.6	667	12.4*	554	29.1	2660	76.2**
Antiplatelets	1569	38.0	386	38.2	1556	28.8**	1205	63.2	2907	83.3**
β-blockers	1148	27.8	302	29.9	1684	31.2	539	28.3	2264	64.9**
ACE inhibitors	868	21.0	188	18.6	787	14.6**	765	40.1	2054	58.8**
Diuretics	2570	62.2	628	62.2	2110	39.1**	1052	55.2	1388	39.8**
α-blockers	198	4.8	56	5.5	257	4.8**	54	2.8	123	3.5
Nitrates	1438	34.8	374	37.0	1627	30.1**	1047	54.9	2435	69.8**
Ca-blockers	1370	33.2	370	36.6	1694	31.4	518	27.2	1177	33.7**

Data are numbers and percentages unless otherwise stated.
*Comparison of dead and alive patients, p<0.05; **p<0.01. †Excluding missing data. ‡Drug uses during the follow-up for post-hospital cohort.
ACE, angiotensin-converting enzyme; PVD, peripheral vascular disease.